Sai Life Sciences (NSE:SAILIFE) Total Liabilities: ₹11,425 Mil (As of Mar. 2026)


NSE:SAILIFE Sai Life Sciences Ltd NSE:SAILIFE
18 GF Score
Price ₹1,208.30
! 5 Warning Signs
View Full Analysis

What is Sai Life Sciences Total Liabilities?

Sai Life Sciences NSE:SAILIFE -0.02% 18 Total Liabilities is ₹11,425 Mil as of Mar. 2026. GuruFocus rates NSE:SAILIFE with a GF Score™ of 18/100. The stock has 5 warning signs investors should review.

Sai Life Sciences's Total Liabilities for the quarter that ended in Mar. 2026 was ₹11,425 Mil.

Sai Life Sciences's quarterly Total Liabilities declined from Sep. 2025 (₹10,618.01 Mil) to Dec. 2025 (₹0.00 Mil) but then increased from Dec. 2025 (₹0.00 Mil) to Mar. 2026 (₹11,424.52 Mil).

Sai Life Sciences's annual Total Liabilities declined from Mar. 2024 (₹12,999.92 Mil) to Mar. 2025 (₹10,316.20 Mil) but then increased from Mar. 2025 (₹10,316.20 Mil) to Mar. 2026 (₹11,424.52 Mil).


Sai Life Sciences Total Liabilities Historical Data

* Premium members only.

The historical data trend for Sai Life Sciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sai Life Sciences Total Liabilities Chart

Sai Life Sciences Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
12,856.65 12,985.55 12,999.92 10,316.20 11,424.52

Sai Life Sciences Quarterly Data
Mar22 Mar23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10,316.20 0.00 10,618.01 0.00 11,424.52
NSE:SAILIFE
18GF Score
Sai Life Sciences Ltd NSE:SAILIFE
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sai Life Sciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Sai Life Sciences's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=8336.78+(1481.24+1606.5
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=11,425

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=36261.4-24836.88
=11,425

Sai Life Sciences's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=8336.78+(1481.24+1606.5
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=11,425

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=36261.4-24836.88
=11,425

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ₹11,425 Mil mean?
Sai Life Sciences (NSE:SAILIFE) has a Total Liabilities of ₹11,425 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Sai Life Sciences and its competitors.
Is Sai Life Sciences' Total Liabilities too high?
Sai Life Sciences' current Total Liabilities is ₹11,425 Mil. Overall, Sai Life Sciences has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sai Life Sciences' Total Liabilities compare to TMO and DHR?
Sai Life Sciences' Total Liabilities of ₹11,425 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Diagnostics & Research company?
A good Total Liabilities depends on the Medical Diagnostics & Research industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Sai Life Sciences and its competitors. Sai Life Sciences's current Total Liabilities is ₹11,425 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sai Life Sciences stock overvalued right now?
Sai Life Sciences (NSE:SAILIFE) has a current Total Liabilities of ₹11,425 Mil. The current Total Liabilities is ₹11,425 Mil. Sai Life Sciences' overall GF Score™ is 18/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Sai Life Sciences (NSE:SAILIFE), the current Total Liabilities is ₹11,425 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sai Life Sciences Business Description

Other Exchanges 544306:India
Address Gachibowli Miyapur Road, L4- 01 & 02, SLN Terminus Survey, Survey no. 133, Gachibowli, Hyderabad, TG, IND, 500032
Sai Life Sciences Ltd is an innovator-focused, contract research, development, and manufacturing organization. It provides end-to-end services across the drug discovery, development, and manufacturing value chain, for small molecule new chemical entities (NCE), to pharmaceutical innovator companies and biotechnology firms. It possesses both; discovery/contract research (CRO) and chemistry, manufacturing, and control (CMC)/contract development and manufacturing organization (CDMO) capabilities. The company has only one reportable segment: contract research, development, and manufacturing. Geographically it operates in India as well as Outside India.
18GF Score

Get the complete analysis for NSE:SAILIFE

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,208.30
Price